These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12955029)

  • 1. Is it necessary to perform prospective randomized studies before sentinel node biopsy can replace routine axillary dissection?
    Noguchi M
    Breast Cancer; 2003; 10(3):179-87. PubMed ID: 12955029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sentinel lymph node biopsy and low axillary node sampling for breast cancer].
    Sawai K; Nakajima H; Ohe S; Mizuta N; Sakaguchi K; Hachimine Y
    Nihon Geka Gakkai Zasshi; 2002 Nov; 103(11):825-30. PubMed ID: 12478860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG-PET for axillary lymph node staging in primary breast cancer.
    Crippa F; Gerali A; Alessi A; Agresti R; Bombardieri E
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy.
    Cantin J; Scarth H; Levine M; Hugi M;
    CMAJ; 2001 Jul; 165(2):166-73. PubMed ID: 11501455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients.
    Noguchi M
    J Surg Oncol; 2001 Feb; 76(2):144-56. PubMed ID: 11223844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience of sentinel node biopsy alone in early breast cancer without further axillary dissection in patients with negative sentinel node.
    Soni NK; Spillane AJ
    ANZ J Surg; 2005 May; 75(5):292-9. PubMed ID: 15932439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
    Specht MC; Fey JV; Borgen PI; Cody HS
    J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of lymphatic tumor burden on sentinel lymph node biopsy results.
    Wong SL; Edwards MJ; Chao C; Simpson D; McMasters KM
    Breast J; 2002; 8(4):192-8. PubMed ID: 12100110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
    Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
    Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.
    Langer I; Marti WR; Guller U; Moch H; Harder F; Oertli D; Zuber M
    Ann Surg; 2005 Jan; 241(1):152-8. PubMed ID: 15622003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendation for axillary lymph node dissection in women with early breast cancer and sentinel node metastasis: A systematic review and meta-analysis of randomized controlled trials using the GRADE system.
    Huang TW; Kuo KN; Chen KH; Chen C; Hou WH; Lee WH; Chao TY; Tsai JT; Su CM; Huang MT; Tam KW
    Int J Surg; 2016 Oct; 34():73-80. PubMed ID: 27562691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Validation study of the sentinel lymph node (SLN) method in invasive breast carcinoma. Personal data and review of the literature].
    Langer I; Zuber M; Köchli OR; Kocher T; Müller-Brand J; Torhorst J; Harder F
    Swiss Surg; 2000; 6(3):128-36. PubMed ID: 10894014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Final results of the Department of Defense multicenter breast lymphatic mapping trial.
    Shivers S; Cox C; Leight G; Beauchamp D; Blumencranz P; Ross M; Reintgen D
    Ann Surg Oncol; 2002 Apr; 9(3):248-55. PubMed ID: 11923131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node mapping in breast cancer: a critical reappraisal of the internal mammary chain issue.
    Manca G; Volterrani D; Mazzarri S; Duce V; Svirydenka A; Giuliano A; Mariani G
    Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):114-26. PubMed ID: 24835288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis.
    Travagli JP; Atallah D; Mathieu MC; Rochard F; Camatte S; Lumbroso J; Garbay JR; Rouzier R
    Eur J Surg Oncol; 2003 May; 29(4):403-6. PubMed ID: 12711299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
    Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
    Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathologic factors predicting axillary lymph node involvement in breast cancer.
    Noguchi M; Kurosumi M; Iwata H; Miyauchi M; Ohta M; Imoto S; Motomura K; Sato K; Tsugawa K
    Breast Cancer; 2000; 7(2):114-23. PubMed ID: 11029782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.